Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by GrahamBon Jan 21, 2021 11:00am
272 Views
Post# 32344683

What did I miss?

What did I miss? 
I have been off the Internet, and in the country hiking in the woods and enjoying life for over a week.

The price action for this stock is incredible!.

First, congratulations to the longs, and traders.

Those who bought in at the nadir in December, may have  had a double-if they sold, which is pretty sweet.

Those who are much longer, at least are approaching their cost basis, which must feel good.
 
I looked for news that would be driving this, however, on my initial review I did not find anything material-so what did I miss?

The delivery of the machine in the UK, had been announced before I took a break, and this never was clearly a sale, so more of the same.

Moving into veterinary medicine, does open up a market, but comes with some risks.
is this another situation, where the machines are going to be tested for prolonged periods before being implemented/accepted?
The sales still have not been realized after years of this technology, not withstanding the recent advances and the new 3.0.
Also, how will this be moved forward with research and marketing sales? There are extremely limited funds-and they are needed to keep the lights on.

 
The big question always is, to me, who is on the other side of the trade. 
 
I see some soft data, with insiders exercising warrants, but there is also some fairly significant sales occurring that have been reported as of yesterday.
Time will tell, if these are true new long-term investors, or traders, insiders…
 
So this is the data, but as I read through a few of the posts, I see lots of speculation…
China investors are buying in now, a buyout from a Chinese company, new investors who are under the story motivated by the veterinary, and of course the one that has been posted many many times, new sales contract that will be announced any day
 
The problem with all of the speculation, is that it is just that. 

I went through and read many of the boards all the way back and I have heard similar rumors about sales, new contracts etc. etc. but none of them came through.
 
As I mentioned, I invest based on facts and the data, and that led me not to make an investment, because the working capital is negative, and the company unless it has a cash infusion, or dilutes, will not be a going entity within the year.(and thats based on Unaudited finacials)
 
These are the facts, whether people like it or not, it is based on review of the financials, and no one here has yet disputed that.  Is not bashing, it is evidence-based investing.
If it is bashing -blame the directors-its thier publication/data-not mine
 
The problem is, that parabolic moves, when unsupported by factual data, in the end come back to earth. 

As Benjamin Graham said- In the short run the stock market is a voting machine, but in the long run it is a weighing machine.

So we need some news to weigh or this will risk losing support and coming back to earth.
 
To the speculators, congratulations and enjoy it-you deserve all of it, and I hope it continues for you. 

I will check in every now and then as new data comes out and keep watching to see what I can learn.  Because in terms of speculation, I have lots to learn

<< Previous
Bullboard Posts
Next >>